Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis

Stroke

Volumn 46, Issue 9, 2015, Pages 2477-2481

  Findlay, Mark D ^a,b   Thomson, Peter C ^b   Fulton, Rachael L ^a   Solbu, Marit D ^a,b   Jardine, Alan G ^a,b   Patel, Rajan K ^a,b   Stevens, Kathryn K ^a,b   Geddes, Colin C ^b   Dawson, Jesse ^a   Mark, Patrick B ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

atrial fibrillation; diabetes mellitus; kidney failure, chronic; renal dialysis; stroke

Indexed keywords

ADULT; AGE; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; END STAGE RENAL DISEASE; FATALITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; AGED; COMORBIDITY; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; PREVALENCE; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA; STROKE; UNITED KINGDOM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; SCOTLAND; STROKE;

EID: 84940398303     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009095     Document Type: Article

References (29)

1. Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603-609. doi: 10.1046/j.1523-1755.2003.00101.x.
2. Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis. 2008;51:255-262. doi: 10.1053/j.ajkd.2007.10.034.
3. Vazquez E, Sanchez-Perales C, Garcia-Garcia F, Castellano P, Garcia-Cortes MJ, Liebana A, et al. Atrial fibrillation in incident dialysis patients. Kidney Int. 2009;76:324-330. doi: 10.1038/ki.2009.185.
4. Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int. 2010;77:1098-1106. doi: 10.1038/ki.2009.477.
5. Fujii H, Kim JI, Yoshiya K, Nishi S, Fukagawa M. Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study. Am J Nephrol. 2011;34:126-134. doi: 10.1159/000329118.
6. Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation. 2014;129:1196-1203. doi: 10.1161/CIRCULATIONAHA.113.004777.
7. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA. Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol. 2013;24:1166-1173. doi: 10.1681/ASN. 2012080841.
8. Green DM, Ropper AH, Kronmal RA, Psaty BM, Burke GL; Cardiovascular Health Study. Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology. 2002;59:314-320.
9. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80.
10. Sozio SM, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 2009;54:468-477. doi: 10.1053/j.ajkd.2009.01.261.
11. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003;14:2623-2631.
12. Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis. 2012;59:249-257. doi: 10.1053/j.ajkd.2011.07.016.
13. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol. 2009;20:2223-2233. doi: 10.1681/ASN.2009030319.
14. Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database. BMJ Open. 2011;1:e000269.
15. Syme PD, Byrne AW, Chen R, Devenny R, Forbes JF. Communitybased stroke incidence in a Scottish population: the Scottish Borders Stroke Study. Stroke. 2005;36:1837-1843. doi: 10.1161/01. STR.0000177873.82478.1c.
16. Wetmore JB, Phadnis MA, Mahnken JD, Ellerbeck EF, Rigler SK, Zhou X, et al. Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients. Clin J Am Soc Nephrol. 2014;9:756-763. doi: 10.2215/CJN.06980713.
17. Wetmore JB, Phadnis MA, Ellerbeck EF, Shireman TI, Rigler SK, Mahnken JD. Relationship between stroke and mortality in dialysis patients. Clin J Am Soc Nephrol. 2015;10:80-89. doi: 10.2215/CJN.02900314.
18. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
19. Seth A, Mossavar-Rahmani Y, Kamensky V, Silver B, Lakshminarayan K, Prentice R, et al. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative. Stroke. 2014;45:2874-2880. doi: 10.1161/STROKEAHA.114.006046.
20. Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, et al. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart. 2014;100:685-690. doi: 10.1136/heartjnl-2013-305417.
21. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
22. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011;6:2662-2668. doi: 10.2215/CJN.04550511.
23. Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol. 2001;21:35-39. doi: 10.1159/000046216.
24. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-e76. doi: 10.1016/j.jacc.2014.03.022.
25. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747. doi: 10.1093/eurheartj/ehs253.
26. Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D, et al; CCS Atrial Fibrillation Guidelines Committee. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30:1114-1130. doi: 10.1016/j. cjca.2014.08.001.
27. Clase CM, Holden RM, Sood MM, Rigatto C, Moist LM, Thomson BK, et al. Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation? Nephrol Dial Transplant. 2012;27:3719-3724. doi: 10.1093/ndt/gfs346.
28. Krüger T, Floege J. Coumarin use in dialysis patients with atrial fibrillation-more harm than benefit? Nephrol Dial Transplant. 2009;24:3284-3285. doi: 10.1093/ndt/gfp368.
29. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-2104. doi: 10.1056/NEJMoa1310907.